Skip to Main Content

Author Details

Eugene C Chen
Department of Drug Metabolism and Pharmacokinetics, Inc.
2010
19
14
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36630933Evaluation of bottom-up modeling of the blood-brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling.Biopharm Drug Dispos2023
35089508High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3.Pharm Res2022
35488474New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.Clin Pharmacol Ther2022
31699807Changes in Organic Anion Transporting Polypeptide Uptake in HEK293 Overexpressing Cells in the Presence and Absence of Human Plasma.Drug Metab Dispos2020
29768081Unremarkable impact of Oatp inhibition on the liver concentration of fluvastatin, lovastatin and pitavastatin in wild-type and Oatp1a/1b knockout mouse.Xenobiotica2019
29786857Effect of OATP1B1/1B3 Inhibitor GDC-0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female Subjects.J Clin Pharmacol2018
30222362Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination.Mol Pharm2018
30335192Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example.Biopharm Drug Dispos2018
29659562Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content.PLoS Biol2018
28230985Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).J Med Chem2017
26507723The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers.Clin Pharmacokinet2016
25695691Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.Clin Cancer Res2015
26528626Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).Mol Pharm2015
25920679Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.Mol Pharmacol2015
24961373OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.Proc Natl Acad Sci U S A2014
22231567Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.Pharmacogenomics J2013
24013810Profiling solute carrier transporters in the human blood-brain barrier.Clin Pharmacol Ther2013
20639304Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function.J Pharmacol Exp Ther2010
20859243Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.Pharmacogenet Genomics2010
  • 1 - 19 of 19

Recommended Authors

The University of New Mexico School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Chulalongkorn University
Career Start Year 2013
Number of shared co-authors 0
Drug Metabolism and Pharmacokinetics
Career Start Year 2009
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 7
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Career Start Year 2007
Number of shared co-authors 3
The Ohio State University
Career Start Year 2005
Number of shared co-authors 4
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Career Start Year 2005
Number of shared co-authors 2
Stanford University
Career Start Year 2004
Number of shared co-authors 4
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 6
Clinical Development
Career Start Year 2003
Number of shared co-authors 0
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 11
Sino-French Hoffmann Institute, Guangzhou Medical University
Career Start Year 2003
Number of shared co-authors 2
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
University of Pittsburgh School of Pharmacy
Career Start Year 2002
Number of shared co-authors 0
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Shionogi & Co.
Career Start Year 1999
Number of shared co-authors 7
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 4
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Washington State University
Career Start Year 1996
Number of shared co-authors 1
University of California
Career Start Year 1996
Number of shared co-authors 0
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 6
and University of Tuebingen, University of Tuebingen
Career Start Year 1995
Number of shared co-authors 5
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Ohio State University
Career Start Year 1994
Number of shared co-authors 2
Ohio State University
Career Start Year 1994
Number of shared co-authors 5
University Hospital Munster
Career Start Year 1989
Number of shared co-authors 2
Novartis
Career Start Year 1988
Number of shared co-authors 1
Stanford University
Career Start Year 1986
Number of shared co-authors 6
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 1

Collaborators

University of California San Francisco
Co-authored papers 13
University of California San Francisco
Co-authored papers 9
Tsinghua University
Co-authored papers 6
Gilead Sciences Inc.
Co-authored papers 5
University of California San Francisco
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 3
Amunix Pharmaceuticals
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Gothenburg
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Center for Visualization, Washington State University
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 1
Collegeville
Co-authored papers 1
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
College of Medicine, The Ohio State University
Co-authored papers 1
College of Medicine, Ewha Womans University
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Western Human Nutrition Research Center
Co-authored papers 1
Center for Drug Design, University of Minnesota
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Seattle Children's Hospital
Co-authored papers 1
University of Colorado
Co-authored papers 1